LASSEN THERAPEUTICS
Lassen Therapeutics develops antibodies as potential treatments for fibrosis, rare diseases, and oncology. The company’s lead candidate is LASN01, a best-in-class monoclonal antibody targeting IL-11 receptor alpha (IL-11R). IL-11, a member of the IL-6 family of cytokines, is a central mediator of fibrosis and blocking its activity has the potential to be more effective than targeting other factors such as TGF-β and CTGF. IL-11 is also a pivotal effector of tumor microenvironment organization and tumor growth, playing a key role as a mediator between cancer and stromal cells.
LASSEN THERAPEUTICS
Industry:
Biotechnology Life Science
Founded:
2018-01-01
Address:
San Diego, California, United States
Country:
United States
Website Url:
http://www.lassentherapeutics.com
Total Employee:
1+
Status:
Active
Contact:
(858) 251-7528
Email Addresses:
[email protected]
Total Funding:
31 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API WordPress Wordpress Plugins Nginx Sitelinks Search Box Microsoft Exchange Online
Similar Organizations
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Autobahn Therapeutics
Autobahn Therapeutics is a developer of regenerative medicines to restore hope for people affected by CNS disorders.
Enliven Therapeutics
Enliven Therapeutics is a precision oncology company developing small molecule therapies to extend and improve patient lives.
Viking Therapeutics
Viking Therapeutics is developing novel therapeutics for patients suffering from metabolic and endocrine disorders.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Alta Partners
Alta Partners investment in Series A - Lassen Therapeutics
Frazier Healthcare Partners
Frazier Healthcare Partners investment in Series A - Lassen Therapeutics
Longwood Fund
Longwood Fund investment in Series A - Lassen Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2021-11-18 | Lassen Therapeutics Appoints Puneet S. Arora M.D. as Chief Medical Officer |
Official Site Inspections
http://www.lassentherapeutics.com Semrush global rank: 8.08 M Semrush visits lastest month: 376
- Host name: 141.193.213.10
- IP address: 141.193.213.10
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Lassen Therapeutics"
Lassen Therapeutics - Crunchbase Company Profile
Organization. Lassen Therapeutics . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ...See details»
About - Lassen
© 2024 Lassen Therapeutics. Site Credits; LinkedInSee details»
Lassen Therapeutics Company Profile | Management and
IL-11 is also a pivotal effector of tumor microenvironment organization and tumor growth, playing a key role as a mediator between cancer and stromal cells. ...Read More. Popular Searches. …See details»
Lassen Therapeutics - Overview, News & Similar companies
IL-11 is also a pivotal effector of tumor microenvironment organization and tumor growth, playing a key role as a mediator between cancer and stromal cells. ... Lassen Therapeutics contact …See details»
Lassen Therapeutics 1, Inc. - Drug pipelines, Patents ... - Patsnap
Www.lassentherapeutics.com. Last update 19 Dec 2024. Overview. Pipeline. Deal. Translational Medicine. Profit. Grant & Funding(NIH) Investment. Financing. Overview. Tags. ... The …See details»
Lassen Therapeutics - LinkedIn
Lassen Therapeutics Biotechnology Research San Diego, California 4,491 followers Combining innovative science, leading technology, and unmatched know-how to create novel medicines.See details»
Our Approach - Lassen
We welcome inquiries with promising ideas for partnerships or research to advance the medical and/or scientific knowledge in our areas of interest. To discuss specific ideas, please contact …See details»
Lassen Therapeutics Company Overview, Contact Details
Biotechnology Research Focus Lassen Therapeutics specializes in developing innovative biotherapeutics to address serious diseases, presenting a valuable opportunity for …See details»
Lassen Therapeutics - Craft
Its lead candidate is LASN01, a monoclonal antibody targeting IL-11 receptor alpha (IL-11R). IL-11 is also a pivotal effector of tumor microenvironment organization and tumor growth, playing …See details»
Lassen Therapeutics Information - RocketReach
Lassentherapeutics.com; View Similar People. Related Companies ViaCyte. 36 $22.6m Interpreta. 40 $10m Evofem Biosciences. 66 $11.4m Mirati Therapeutics. 287 $72.8m HUYABIO …See details»
Lassen Therapeutics - VentureRadar
Similar Companies: Tourmaline Bio USA n/a Tourmaline Bio is dedicated to developing transformative medicines aimed at establishing new standards-of-care for patients with high …See details»
Lassen Therapeutics Announces the Appointment of a Highly …
IL-11 is also an important effector of tumor microenvironment organization, playing a key role as a mediator between cancer and stromal cells. For more information, please visit …See details»
Lassen Therapeutics - VentureRadar
IL-11, a member of the IL-6 family of cytokines, is a central mediator of fibrosis and blocking its activity has the potential to be safer than and additive to other anti-fibrotic therapeutic …See details»
Lassen Therapeutics Announces the Appointment of a Highly …
Oct 7, 2021 IL-11 is also an important effector of tumor microenvironment organization, playing a key role as a mediator between cancer and stromal cells. For more information, please visit …See details»
Lassen Therapeutics Launches to Discover and Develop Novel …
Jun 17, 2020 IL-11 is also a pivotal effector of tumor microenvironment organization and tumor growth, playing a key role as a mediator between cancer and stromal cells. For more …See details»
News - Lassen
19 December 2023 | Lassen Therapeutics Announces Closing of Oversubscribed $85 Million Series B Financing and Announces First Patient Dosed in the Phase 1 Trial Evaluating …See details»
Lassen Therapeutics-Lassen Therapeutics 1, Inc.-企业详情 …
查看医药魔方InvestGO®数据库Lassen Therapeutics的公司信息。Lassen Therapeutics（Lassen Therapeutics 1, Inc.），公司简介：Lassen Therapeutics develops antibodies as potential …See details»
Lassen Therapeutics Announces Formation of Scientific Advisory …
San Diego, CA, December 16, 2020 – Lassen Therapeutics, a biotech company developing innovative antibodies as potential treatments for fibrosis, rare diseases and oncology, today …See details»
Lassen Therapeutics Launches to Discover and Develop Novel …
Jun 17, 2020 IL-11 is also a pivotal effector of tumor microenvironment organization and tumor growth, playing a key role as a mediator between cancer and stromal cells. ... For more …See details»